FDA Acceptance of Supplement for Nizoral Anti-Dandruff
The FDA has accepted a supplemental application for Nizoral Anti-Dandruff, containing ketoconazole.
Asset / Drug
Drug and asset intelligence for Nizoral with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.